Natalizumab for multiple sclerosis: a complicated treatment

被引：5

作者：

Keegan, B. Mark ^{[1
]}

机构：

[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA

来源：

LANCET NEUROLOGY | 2011年 / 10卷 / 08期

关键词：

PLACEBO-CONTROLLED TRIAL; PATIENT SELECTION; RECOMMENDATIONS;

D O I：

10.1016/S1474-4422(11)70150-8

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：677 / 678

页数：2

共 8 条

[1]

Clifford D, 2011, NEUROLOGY, V76, pA28

[2] Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring [J].

Kappos, Ludwig ;

Bates, David ;

Hartung, Hans-Peter ;

Havrdova, Eva ;

Miller, David ;

Polman, Chris H. ;

Ravnborg, Mods ;

Houser, Stephen L. ;

Rudick, Richard A. ;

Weiner, Howard L. ;

O'Connor, Paul W. ;

King, John ;

Radue, Ernst Wilhelm ;

Yousry, Tarek ;

Major, Eugene O. ;

Clifford, David B. .

LANCET NEUROLOGY, 2007, 6 (05) :431-441

[3] Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring [J].

Kappos, Ludwig ;

Bates, David ;

Edan, Gilles ;

Eraksoy, Mefkure ;

Garcia-Merino, Antonio ;

Grigoriadis, Nikolaos ;

Hartung, Hans-Peter ;

Havrdova, Eva ;

Hillert, Jan ;

Hohlfeld, Reinhard ;

Kremenchutzky, Marcelo ;

Lyon-Caen, Olivier ;

Miller, Ariel ;

Pozzilli, Carlo ;

Ravnborg, Mads ;

Saida, Takahiko ;

Sindic, Christian ;

Vass, Karl ;

Clifford, David B. ;

Hauser, Stephen ;

Major, Eugene O. ;

O'Connor, Paul W. ;

Weiner, Howard L. ;

Clanet, Michel ;

Gold, Ralf ;

Hirsch, Hans H. ;

Radue, Ernst-Wilhelm ;

Sorensen, Per Soelberg ;

King, John .

LANCET NEUROLOGY, 2011, 10 (08) :745-758

[4] Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function [J].

Khatri, B. O. ;

Man, S. ;

Giovannoni, G. ;

Koo, A. P. ;

Lee, J. -C. ;

Tucky, B. ;

Lynn, F. ;

Jurgensen, S. ;

Woodworth, J. ;

Goelz, S. ;

Duda, P. W. ;

Panzara, M. A. ;

Ransohoff, R. M. ;

Fox, R. J. .

NEUROLOGY, 2009, 72 (05) :402-409

[5] Natalizumab Drug Holiday in Multiple Sclerosis: Poorly Tolerated [J].

Killestein, Joep ;

Vennegoor, Anke ;

Strijbis, Eva M. ;

Seewann, Alexandra ;

van Oosten, Bob W. ;

Uitdehaag, Bernard M. J. ;

Polman, Chris H. .

ANNALS OF NEUROLOGY, 2010, 68 (03) :392-395

[6] IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER WITHDRAWAL OF NATALIZUMAB? [J].

Lenhard, T. ;

Biller, A. ;

Mueller, W. ;

Metz, I. ;

Schoenberger, J. ;

Wildemann, B. .

NEUROLOGY, 2010, 75 (09) :831-833

[7] MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS [J].

Miller, D. H. ;

Soon, D. ;

Fernando, K. T. ;

MacManus, D. G. ;

Barker, G. J. ;

Yousry, T. A. ;

Fisher, E. ;

O'Connor, P. W. ;

Phillips, J. T. ;

Polman, C. H. ;

Kappos, L. ;

Hutchinson, M. ;

Havrdova, E. ;

Lublin, F. D. ;

Giovannoni, G. ;

Wajgt, A. ;

Rudick, R. ;

Lynn, F. ;

Panzara, M. A. ;

Sandrock, A. W. .

NEUROLOGY, 2007, 68 (17) :1390-1401

[8] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis [J].

Polman, CH ;

O'Connor, PW ;

Havrdova, E ;

Hutchinson, M ;

Kappos, L ;

Miller, DH ;

Phillips, JT ;

Lublin, FD ;

Giovannoni, G ;

Wajgt, A ;

Toal, M ;

Lynn, F ;

Panzara, MA ;

Sandrock, AW .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09) :899-910

← 1 →